Schwartz P, Meischen S J, Gale G R, Atkins L M, Smith A B, Walker E M
Cancer Treat Rep. 1977 Nov;61(8):1519-25.
The structure of the antitumor agent, dichloro(1,2-diaminocyclohexane)platinum(II) (NSC-194814), was modified by replacing the chlorides with organic or inorganic anions. Eighteen new platinum complexes were so isolated and their antitumor properties against the L1210 leukemia in C57BL/6 X DBA/2 mice were evaluated. Most of the complexes were readily soluble in water and some had enhanced antitumor activity compared to the parent dichloro complex. In addition, increased solubility with retention of significant antitumor activity was obtained by oxidizing the parent dichloroplatinum(II) complex with halogen or peroxide to give two platinum(IV) complexes. Some previously reported platinum complexes with phosphorus, selenium, or tellurium electron donor ligands were also synthesized and assessed for antitumor action, but these did not show appreciable activity.
通过用有机或无机阴离子取代氯化物,对抗肿瘤剂二氯(1,2 - 二氨基环己烷)铂(II)(NSC - 194814)的结构进行了修饰。如此分离出了18种新的铂配合物,并评估了它们对C57BL / 6 X DBA / 2小鼠L1210白血病的抗肿瘤特性。大多数配合物易溶于水,与母体二氯配合物相比,有些配合物具有增强的抗肿瘤活性。此外,通过用卤素或过氧化物氧化母体二氯铂(II)配合物得到两种铂(IV)配合物,在保持显著抗肿瘤活性的同时提高了溶解度。还合成了一些先前报道的带有磷、硒或碲电子供体配体的铂配合物,并评估了它们的抗肿瘤作用,但这些配合物没有显示出明显的活性。